D475-2619 Screening compound: 3-{1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-N-(2-fluorophenyl)propanamide

D475-2619 Screening compound: 3-{1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-N-(2-fluorophenyl)propanamide
D475-2619 Screening compound: 3-{1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-N-(2-fluorophenyl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D475-2619
3-{1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-N-(2-fluorophenyl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D475-2619

Molecular Formula

C22H18ClFN4O2S (C22 H18 ClFN4 O2 S)

Compound Name

3-{1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-N-(2-fluorophenyl)propanamide

IUPAC name

3-{1-[4-(4-chlorophenyl)-13-thiazol-2-yl]-5-hydroxy-3-methyl-1H-pyrazol-4-yl}-N-(2-fluorophenyl)propanamide

SMILES

Cc(c(CCC(Nc(cccc1)c1F)=O)c1O)nn1-c1nc(-c(cc2)ccc2Cl)cs1

InChI

InChI=1S/C22H18ClFN4O2S/c1-13-16(10-11-20(29)25-18-5-3-2-4-17(18)24)21(30)28(27-13)22-26-19(12-31-22)14-6-8-15(23)9-7-14/h2-9,12,30H,10-11H2,1H3,(H,25,29)

InChI Key

CTFDSWTUWDQWMB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14831252

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

456.93

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.763

Distribution Coefficient, logD

2.777

Water Solubility, LogSw

-4.68

Polar Surface Area

61.817

Acid Dissociation Constant (pKa)

5.42

Base Dissociation Constant (pKb)

5.09

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.60

D475-2619 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with D475-2619 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D475-2619?
Check Price and Availability of D475-2619, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D475-2619 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D475-2619
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D475-2619
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D475-2619 available by request